The rate of HPV head & neck cancers is rapidly rising: what more can be done in prevention?

Objectives:

1. Describe the burden of disease of head and neck cancers in Canadians
2. Explain the complexity of challenges for patients with head and neck cancer
3. Review the efficacy of HPV vaccine to lower burden of head and neck HPV cancers
4. Recognize signs and symptoms of head and neck cancer
5. Discuss potential screening methods
6. Develop a better understanding of the perspectives of a head and neck cancer patient

Presenters:

• Dr. Melissa Henry PhD – Associate Professor and FRQS Senior Clinician-Scientist, Gerald Bronfman Department of Oncology, McGill University – Director, International Psycho-Oncology Society (IPOS)
• Dr. Denis Soulieres MD, MSc, FRCPC – Hematologist and Medical Oncologist, Centre Hospitalier de l’Université de Montréal – Clinical researcher and Molecular Biologist
• John-Peter Bradford BA, MA, ABD, PhD – Head and Neck Cancer Thriver & Advocate – Co-founder, LSTN (Life-Saving Therapies Network)

Moderator: Dr. Marc Steben MD,CCFM, FCFM – Co-President, HPV Global Action/ VPH Action Globale – Chair, Canadian Network on HPV Prevention – Board Member, International Papillomavirus Society

REGISTER